Data last refreshed 17 days ago — analysis may not reflect the latest market data

SNPSSNPS

US

NEUTRAL

$446.07

P/E

103.38

PEG

FCF Yield

Rev Growth YoY

+39.5% YoY

Gross Margin

73.5%

Health Score

7/10

D/E Ratio

0.48

Confidence

LOW


Advertisement

Business Snapshot

Synopsys (SNPS) is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP). The company's primary revenue-generating products include software tools used to design and verify integrated circuits, along with pre-designed IP blocks that accelerate chip development. Synopsys operates in the highly concentrated EDA market, where it is a dominant duopoly player alongside Cadence Design Systems, giving it significant competitive pricing power and customer stickiness. The company is a large-cap technology firm, noted for its 73.5% gross margin, which reflects the high-value, software-centric nature of its business. A key defining characteristic is its irreplaceable role in the global semiconductor supply chain, as nearly every complex chip is designed using its tools.

Advertisement

Financial Health

The company reports a strong gross margin of 73.5%, indicating a high-quality earnings base, though a net margin of 8.9% is somewhat compressed relative to the gross profit level. The balance sheet is healthy, with a conservative debt/equity ratio of 0.48x and a current ratio of 1.62x, suggesting ample liquidity to cover short-term obligations...

Risk Assessment

  • VALUATION — P/E of 103.38x is significantly higher than the sector average of 22x, demanding near-perfect execution to justify the premium.
  • EARNINGS QUALITY — Earnings growth of -68.8% severely contradicts the strong top-line growth, raising questions about business model leverage and cost control.
  • INSIDER ACTIVITY — Insiders have recorded 1 sell vs. 0 buys over the last 90 days, a net negative signal that reduces confidence at the current valuation.
  • TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
  • DATA QUALITY — Key metrics like TTM Revenue, TTM Net Income, and Free Cash Flow are absent, limiting the depth of the fundamental analysis....

The company reports a strong gross margin of 73.5%, indicating a high-quality earnings base, though a net margin of 8.9% is somewhat compressed relative to the gross profit level. The balance sheet is healthy, with a conservative debt/equity ratio of 0.48x and a current ratio of 1.62x, suggesting ample liquidity to cover short-term obligations. Free cash flow and FCF yield are not calculable from the available data, limiting a full assessment of cash generation. Return on equity stands at a low 2.6%, which is a point of caution. Overall, the company’s solid balance sheet and high-margin business model suggest it has the financial flexibility for reinvestment, but the low ROE and uncertain free cash flow profile warrant monitoring.

- VALUATION — P/E of 103.38x is significantly higher than the sector average of 22x, demanding near-perfect execution to justify the premium. - EARNINGS QUALITY — Earnings growth of -68.8% severely contradicts the strong top-line growth, raising questions about business model leverage and cost control. - INSIDER ACTIVITY — Insiders have recorded 1 sell vs. 0 buys over the last 90 days, a net negative signal that reduces confidence at the current valuation. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - DATA QUALITY — Key metrics like TTM Revenue, TTM Net Income, and Free Cash Flow are absent, limiting the depth of the fundamental analysis.

Unlock the full AI report

Full 8-section analysis includes:

Financial Health
Growth Momentum
Valuation Snapshot
Risk Flags
Sentiment & News
Technical Snapshot
Full Verdict with Confidence Rating
Last updated 414 hours ago · Data sourced from FMP & Finnhub · Not financial advice